Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.5 GBX | 0.00% | +8.51% | -58.20% |
04-16 | Faron Pharmaceuticals Oy Confirms Plans for the Coming Months | CI |
04-15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Sales 2024 * | 14.4M 15.4M 21.05M | Sales 2025 * | 39.09M 41.8M 57.14M | Capitalization | 107M 115M 157M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.42M -8.77M | Net income 2025 * | -4M -4.28M -5.85M | EV / Sales 2024 * | 9.56 x |
Net Debt 2024 * | 30.6M 32.72M 44.72M | Net cash position 2025 * | 42.27M 45.19M 61.78M | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
-4.85
x | P/E ratio 2025 * |
-9.6
x | Employees | 34 |
Yield 2024 * |
1.01% | Yield 2025 * |
-
| Free-Float | 60.17% |
Latest transcript on Faron Pharmaceuticals Oy
1 week | +8.51% | ||
Current month | -7.27% | ||
1 month | -8.93% | ||
3 months | -56.03% | ||
6 months | -55.26% | ||
Current year | -58.20% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 02-12-31 | |
Founder | 46 | 02-12-31 | |
Founder | 70 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 70 | 02-12-31 | |
Chairman | 60 | 23-03-23 | |
Founder | 46 | 02-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 127.5 | 0.00% | 1,513 |
24-04-25 | 127.5 | 0.00% | 195 |
24-04-24 | 127.5 | 0.00% | 22,023 |
24-04-23 | 127.5 | +6.25% | 1,464 |
24-04-22 | 120 | +2.13% | 29,914 |
Delayed Quote London S.E., April 26, 2024 at 11:35 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.20% | 114M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- FARN Stock